Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg |
SHISA9 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1302 | Noelin Blocking Peptide (AC1302) | 250 µg |
Noelin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1303 | Human Stratifin Protein (AC1303) | 5 µg |
Tyr-3/Trp- 5 Monooxygenase Activation Protein Sigma Human Recombinant
|
inquiry |
| ACPP-1304 | Netrin 1 Blocking Peptide (AC1304) | 250 µg |
Netrin 1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1305 | Aph 1b Blocking Peptide (AC1305) | 250 µg |
Aph 1b Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1306 | FGFR2 Blocking Peptide (AC1306) | 250 µg |
FGFR2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg |
NPY2R Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg |
TrkA Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg |
CCR5 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1310 | SHC Blocking Peptide (AC1310) | 250 µg |
SHC Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1311 | Human LIF Protein (AC1311) | 3 x 2 µg |
Leukemia Inhibitory Factor Human Recombinant
|
inquiry |
| ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg |
Glial-Derived Neurotrophic Factor Human Recombinant
|
inquiry |
| ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg |
Norepinephrine Transporter Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg |
Syndecan-1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1315 | GTP cyclohydrolase 1 Blocking Peptide (AC1315) | 250 µg |
GTP cyclohydrolase 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.